Time on dialysis and cancer risk after kidney transplantation

Transplantation

Volumn 95, Issue 1, 2013, Pages 114-121

  Wong, Germaine ^a,b,c   Turner, Robin M ^a   Chapman, Jeremy R ^c   Howell, Martin ^a,b   Lim, Wai H ^d   Webster, Angela C ^a,b,c   Craig, Jonathan C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Cancer; Dialysis; Epidemiology; Transplantation

Indexed keywords

ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PERITONEAL DIALYSIS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; REGISTER; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TREATMENT DURATION; URINARY TRACT CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 84872055400     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827743b4     Document Type: Article

References (24)

1. Vajdic CM, van Leeuwen MT, McDonald SP, et al. Increased incidence of squamous cell carcinoma of eye after kidney transplantation. J Natl Cancer Inst 2007; 99: 1340.
2. Webster AC, Craig JC, Simpson JM, et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15, 183 recipients. Am J Transplant 2007; 7: 2140.
3. Stewart JH, Vajdic CM, van Leeuwen MT, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dialysis Transplant 2009; 24: 3225.
4. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886.
5. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis [review] [30 refs]. Lancet 2007; 370: 59.
6. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823.
7. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003; 14: 197.
8. Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant 2011; 11: 86.
9. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93.
10. Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol 2009; 20: 1341.
11. Jorgensen L, Heuch I, Jenssen T, et al. Association of albuminuria and cancer incidence. J Am Soc Nephrol 2008; 19: 992.
12. Gris JC, Branger B, Vecina F, et al. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994; 46: 807.
13. Wilson WE, Kirkpatrick CH, Talmage DW. Immunologic responsiveness in uremia. Ann Intern Med 1965; 62: 1.
14. Moss SF, Blaser MJ. Mechanisms of disease: inflammation and the origins of cancer [review] [65 refs]. Nat Clin Pract Oncol 2001; 2: 90.
15. Thun MJ, Henley SJ, Gansler T. Inflammation and cancer: an epidemiological perspective [review] [57 refs]. Novartis Found Symp 1949; 256: 6.
16. Schwartsburd PM. Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control [review] [53 refs]. Cancer Metastasis Rev 2003; 22: 95.
17. Zhou B, Latouche A, Rocha V, et al. Competing risks regression for stratified data. Biometrics 2011; 67: 661.
18. Forsblom C, Harjutsalo V, Thorn LM, et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011; 22: 537.
19. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007; 13: t-65.
20. Holley JL. Screening, diagnosis, and treatment of cancer in long-term dialysis patients [review] [51 refs]. Clin J Am Soc Nephrol 2007; 2: 604.
21. Holley JL. Preventive medical screening is not appropriate for many chronic dialysis patients. Semin Dialysis 2000; 13: 369.
22. Webster AC, Supramaniam R, O'Connell DL, et al. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology 2010; 15: 491.
23. Zhang X, Zhang MJ. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Comput Methods Programs Biomed 2011; 101: 87.
24. R Foundation for Statistical Computing, Vienna, Austria, 2012.